Product Program year 2025 Source: CMS Open Payments

Fibrinet

Device Orthopedics

PDI 10850014593039

Open in the dashboard

General payments

$236,344

527 payments

Research payments

$62,512

10 payments

Through program year 2025, $236,344 in general payments and $62,512 in research payments were reported against Fibrinet (Orthopedics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $13,233 32
2024 General $40,222 47
2024 Research $50,929 4
2023 General $43,755 42
2023 Research $10,335 5
2022 General $45,227 137
2022 Research $1,248 1
2021 General $93,907 269

Breakdown

Who paid General payments · program years 2021–2025
  1. Royal Biologics $236,344 527 payments
Top recipients General payments · program year 2025
  1. Faheem Sandhu Neurological Surgery · Clinton, MD $3,430 26% · 5 payments
  2. James Yue Orthopaedic Surgery · Shelton, CT $1,606 12% · 4 payments
  3. Charles Gordon Orthopaedic Surgery of the Spine · Daphne, AL $1,606 12% · 4 payments
  4. Daniel Popowitz Podiatrist, Foot & Ankle Surgery · New York, NY $1,500 11% · 1 payment
  5. Adam Lipson Neurological Surgery · Union, NJ $1,070 8% · 4 payments

The top 5 of 10 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurological Surgery $5,371 41% · 3 practitioners
  2. Orthopaedic Surgery $3,556 27% · 3 practitioners
  3. Podiatrist, Foot & Ankle Surgery Podiatrist $2,100 16% · 2 practitioners
  4. Orthopaedic Surgery of the Spine Orthopaedic Surgery $1,606 12% · 1 practitioner
  5. Podiatrist, Primary Podiatric Medicine Podiatrist $600 5% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. District of Columbia $4,310 33% · 2 recipients
  2. New York $2,570 19% · 2 recipients
  3. Connecticut $2,477 19% · 2 recipients
  4. New Jersey $2,270 17% · 3 recipients
  5. Alabama $1,606 12% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

527 general · 10 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record